• Corpus ID: 31185233

Treating male retention patients with temporary prostatic stent in a large urology group practice.

@article{Roach2017TreatingMR,
  title={Treating male retention patients with temporary prostatic stent in a large urology group practice.},
  author={Richard M. Roach},
  journal={The Canadian journal of urology},
  year={2017},
  volume={24 2},
  pages={
          8776-8781
        }
}
  • R. Roach
  • Published 1 April 2017
  • Medicine
  • The Canadian journal of urology
Men with either chronic or temporary urinary retention symptoms are common patients treated in a urology practice. Both indwelling and intermittent catheterization are widely used to treat this condition. These approaches are associated with significant complications including infection and reduced quality-of-life. Infection is a target for quality improvement and cost reduction strategies in most care settings today. We use a temporary prostatic stent (TPS) to address these issues in our… 

Figures and Tables from this paper

Extended Use of The Spanner® Temporary Prostatic Stent in Catheter-Dependent Men with Comorbidities

TLDR
It is demonstrated that catheter-dependent men with sufficient bladder contractility can achieve volitional voiding and successful bladder drainage using The Spanner Temporary Prostatic Stent for extended periods of time.

Using Temporary Prostatic Stents to Eliminate Bacterial Colonization in Men with Chronic Indwelling Catheters: A Pilot Study

TLDR
It is suggested that replacing an IUC with a TPS interrupts the cycle of bacterial colonization in the urinary tract and could be a strategy for eliminating multi-drug resistant organisms from the urinary tracts of men with urinary retention.

References

SHOWING 1-10 OF 14 REFERENCES

Experience with the spanner prostatic stent in patients unfit for surgery: an observational study.

TLDR
In patients with acute and chronic symptoms of bladder-outlet obstruction secondary to benign or malignant disease who were unfit for surgery because of age or cardiorespiratory disease, a temporary stent such as the AbbeyMoor Spanner should be used for only 3 months as a trial of stenting followed by atrial of stent-free voiding, with the patient converted to permanent prostatic stenting if voiding is unsuccessful.

Infectious complications associated with the use of temporary prostatic urethral stents in patients with benign prostatic hyperplasia.

TLDR
Infection rates with TPUS in BPH patients are acceptable and early removal may prevent colonization, and logistic regression was used to examine the predictors of infection at any point.

Postoperative Urinary RetentionAnesthetic and Perioperative Considerations

TLDR
An evidence-based approach to prevention and management of POUR during the perioperative period is proposed, which may be responsible for bladder overdistension, urinary tract infection, and catheter-related complications.

A novel temporary prostatic stent for the relief of prostatic urethral obstruction

TLDR
To determine the effect of a novel temporary prostatic stent on variables of voiding function and quality of life among patients with prostatic urethral obstruction, The SpannerTM, AbbeyMoor Medical, Inc. is used.

Clinical and economic consequences of nosocomial catheter-related bacteriuria.

  • S. Saint
  • Medicine, Biology
    American journal of infection control
  • 2000